Global Glioblastoma Multiforme Treatment Market Size & Outlook

The glioblastoma multiforme treatment industry worldwide is expected to reach a projected revenue of US$ 318.9 million by 2030. A compound annual growth rate of -20% is expected of the worldwide glioblastoma multiforme treatment industry from 2024 to 2030.
Revenue, 2023 (US$M)
$1,515.1
Forecast, 2030 (US$M)
$318.9
CAGR, 2024 - 2030
-20%
Report Coverage
Worldwide

Global glioblastoma multiforme treatment market, 2018-2030 (US$M)

Global glioblastoma multiforme treatment market highlights

  • The global glioblastoma multiforme treatment market generated a revenue of USD 1,515.1 million in 2023 and is expected to reach USD 318.9 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of -20% by 2030.
  • In terms of segment, hospitals accounted for a revenue of USD 1,515.1 million in 2023.
  • Hospitals is the most lucrative end-use segment registering the fastest growth during the forecast period.
  • In terms of region, Europe was the largest revenue generating market in 2023.

Global data book summary

Market revenue in 2023USD 1,515.1 million
Market revenue in 2030USD 318.9 million
Growth rate-20% (CAGR from 2023 to 2030)
Largest segmentHospitals
Fastest growing segmentHospitals
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHospitals

Other key industry trends

  • In terms of revenue, the North America accounted for 0.1% of the global glioblastoma multiforme treatment market in 2023.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Glioblastoma Multiforme Treatment Market Scope

Glioblastoma multiforme treatment market segmentation & scope
Clinics
Ambulatory Surgical Centers
Treatment
Surgery
Radiation therapy
Chemotherapy
Targeted Therapy
Tumor Treating Field (TTF) Therapy
Immunotherapy

Glioblastoma Multiforme Treatment Market Companies

Name Profile # Employees HQ Website

Global glioblastoma multiforme treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.


Hospitals was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global glioblastoma multiforme treatment market based on hospitals covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Glioblastoma Multiforme Treatment End-Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • Global Glioblastoma Multiforme Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
    • Surgery
    • Radiation therapy
    • Chemotherapy
    • Targeted Therapy
    • Tumor Treating Field (TTF) Therapy
    • Immunotherapy

Reasons to subscribe to Global glioblastoma multiforme treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global glioblastoma multiforme treatment market databook

  • Our clientele includes a mix of glioblastoma multiforme treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global glioblastoma multiforme treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global glioblastoma multiforme treatment gbm market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more